Starbucks Corp. sell BiotechBee
Start price
22.09.22
/
60%
€86.57
Target price
31.12.24
€75.00
Performance (%)
5.46%
End price
21.12.22
€91.30
Summary
This prediction ended on 21.12.22 with a price of €91.30. The SELL prediction by BiotechBee shows the price for Starbucks Corp. slightly increased by 5.46% during the runtime of the prediction. Dividends of €0.53 are taken into consideration when calculating the performance. BiotechBee has 60% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Starbucks Corp. | 0.212% | 0.212% | -17.771% |
iShares Core DAX® | -1.822% | -1.170% | 11.771% |
iShares Nasdaq 100 | -0.241% | 1.961% | 40.760% |
iShares Nikkei 225® | -2.310% | -1.758% | 21.493% |
iShares S&P 500 | -0.835% | 1.309% | 28.068% |
According to BiotechBee what are the pros and cons of Starbucks Corp. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by BiotechBee for this prediction
In the thread Starbucks Corp. diskutieren
Sell mit Kursziel 75,0
In the thread Trading Starbucks Corp.
Sell beendet